Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Published on by Forensic Scientist

Mrs. Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University | Poland

Mrs. Monika Prylińska-Jaśkowiak is an emerging clinician-scientist whose professional journey reflects a rare balance between medical practice, academic excellence, and translational research. She earned her Doctor of Medical Sciences degree from Collegium Medicum, Nicolaus Copernicus University in Toruń, where her doctoral research focused on the relationship between the gut microbiome and chronic fatigue syndrome, integrating clinical insight with advanced molecular and bioinformatic analyses. As a specialist pediatrician at the Voivodeship Children’s Hospital in Bydgoszcz, she combines her research background with everyday patient care and is currently pursuing specialization in pediatric rheumatology. Her scientific contributions include peer-reviewed publications such as The gut microbial composition is different in chronic fatigue syndrome than in healthy controls (Scientific Reports, 2025), and review papers in the Journal of Education, Health and Sport (2022), widely cited for summarizing current knowledge on CFS/ME and human gut microbiota. Mrs. Monika Prylińska-Jaśkowiak’s research interests encompass pediatric immunology, microbiome–immune interactions, and chronic inflammatory diseases, with a focus on precision diagnostics and targeted therapy development. Actively engaged in professional societies including the Polish Pediatric Society and the Polish Society of Vaccinology, she continues to expand her expertise through certified courses in resuscitation, vaccinology, and emergency pediatrics. Her commitment to continuous learning, clinical excellence, and evidence-based innovation exemplifies the spirit of a modern physician-scientist dedicated to improving child health and advancing medical science.

Profile: ORCID | LinkedIn

Featured Publications

• Prylińska, M., & Kożuchowski, M. (2022, September 28). The human gastrointestinal tract microbiota in health – current knowledge summary. Journal of Education, Health and Sport, 12(10). https://doi.org/10.12775/JEHS.2022.12.10.005

• Kożuchowski, M., & Prylińska, M. (2022, April 30). The proper functioning of the sense of smell and its disturbances on the example of COVID-19 infection. Journal of Education, Health and Sport, 12(4). https://doi.org/10.12775/JEHS.2022.12.04.026

Yang Li | Biology and Life Sciences | Best Researcher Award

Published on by Forensic Scientist

Mrs. Yang Li | Biology and Life Sciences | Best Researcher Award

The First Affiliated Hospital of Kunming Medical University | China

Mrs. Yang Li is a committed attending doctor at the First Affiliated Hospital of Kunming Medical University, where she integrates clinical service with translational research. With a strong foundation in endocrinology and metabolic diseases, her academic and clinical endeavors focus on diabetic complications, particularly type 2 diabetic nephropathy. Her contributions to both provincial and national-level projects highlight her dedication to improving patient outcomes through evidence-based research.

Professional Profile

Scopus

Education

Mrs. Yang Li began her academic journey in clinical medicine at Tongji Medical College, one of China’s top-tier medical institutions. She specialized in endocrinology and metabolic diseases, laying a strong academic foundation in chronic disease management, hormonal regulation, and metabolic dysfunctions. Her education was marked by excellence in both theoretical understanding and hands-on training in hospital environments. Continuing her commitment to academic advancement, she is currently pursuing an academic master’s degree, with research embedded into her clinical role. Her educational path reflects a lifelong commitment to improving the diagnosis, treatment, and understanding of chronic metabolic disorders such as diabetes and its complications.

Experience

Mrs. Li’s professional experience encompasses extensive clinical practice, medical education, and rigorous scientific research. At the First Affiliated Hospital of Kunming Medical University, she functions both as a frontline clinician and a research investigator. Her clinical work has given her firsthand insight into the complexities of diabetic complications, particularly diabetic nephropathy. This experience fuels her research endeavors, allowing her to design studies that are both clinically relevant and methodologically sound. She has independently led two provincially funded research projects and participated in two nationally funded projects under the National Natural Science Foundation of China. Her dual role has equipped her with the skills to integrate clinical questions into laboratory settings and translate scientific findings back into patient care protocols.

Research Interest

Mrs. Li’s core research interests revolve around type 2 diabetic nephropathy, particularly the molecular mechanisms driving renal damage in diabetic patients. Her work investigates the interplay between metabolic stress, adipose tissue function, vascular endothelial integrity, and renal cellular injury. Of special interest is the role of perirenal adipose tissue in modulating the onset and progression of diabetic kidney disease, a relatively underexplored area that may yield novel diagnostic and therapeutic strategies. She is also interested in transcriptomics, signaling pathways such as TGF-β1, and the protective role of ACE2–Ang-(1-7)–Mas receptor axes in pancreatic and renal tissues. Through her research, she aims to uncover early biomarkers and develop targeted interventions that can prevent or slow the progression of diabetic nephropathy.

Award

Mrs. Yang Li is an exemplary nominee for the Best Researcher Award, a recognition that would honor her persistent and impactful contributions to clinical science. Her ability to lead government-funded projects, publish in respected international journals, and remain active in frontline patient care places her among the most promising early-career physician-researchers in China. The translational nature of her research directly addresses one of the world’s most pressing public health concerns: diabetes and its complications. Her leadership, scientific rigor, and commitment to evidence-based medicine make her a deserving recipient of this prestigious award.

Publications

Mrs. Yang Li has published four peer-reviewed articles in reputable SCI-indexed journals, reflecting her growing influence in the field of diabetic complications. Each of her publications contributes to a deeper understanding of the pathophysiological mechanisms behind diabetes and its impact on vital organs:

Title: Ang (1-7) protects islet endothelial cells from palmitate-induced apoptosis via AKT, eNOS, p38 MAPK, and JNK pathways
Journal: Journal of Diabetes Research
Published on: 2014
Citation: Cited by 64 articles

Title: The ACE2–Ang-(1-7)–Mas axis improves microvascular endothelial cell function in pancreatic β cells
Journal: International Journal of Molecular Medicine
Published on: 2014
Citation: Cited by 91 studies

Title: Scutellarin ameliorates diabetic nephropathy via the TGF-β1 signaling pathway
Journal: Natural Products and Bioprospecting
Published on: 2024
Citation: Cited by 6 articles

Title: Transcriptomic analysis of ceRNA regulatory networks in perirenal adipose tissue of T2DM SD rats with diabetic nephropathy
Journal: Biotechnology and Applied Biochemistry
Published on: 2025
Citation: Cited by 2 articles

Conclusion

Mrs. Yang Li exemplifies the integration of clinical excellence and scientific innovation. Her work has advanced the understanding of diabetic nephropathy at both cellular and systemic levels, contributing new insights into its prevention and treatment. By combining patient care with a robust research portfolio, she continues to bridge the gap between laboratory discovery and clinical application. Her academic background, research leadership, and impactful publications collectively highlight her qualifications for prestigious research recognition. With her contributions resonating across endocrinology and nephrology, Mrs. Yang Li stands as a valuable asset to the medical and scientific community.

Saeid Amiri Zadeh Fard | Microbiology | Best Researcher Award

Published on by Forensic Scientist

Dr. Saeid Amiri Zadeh Fard | Microbiology | Best Researcher Award

Shiraz University of Medical Sciences | Iran

Dr. Saeid Amiri Zadeh Fard is a distinguished biomedical researcher specializing in virology and biotechnology. With extensive experience in viral suppression techniques, particularly short hairpin RNA (shRNA)-based strategies, his work aims to develop innovative therapeutic solutions for viral and immunological diseases. Known for his meticulous research approach and organizational skills, he has made significant contributions to biomedical engineering and immunotherapy.

Professional profile👤

Google Scholar

ORCID

Strengths for the Awards✨

  • Extensive Research Experience:

    • Over two decades of experience in biomedical research, with a focus on virology, RNA analysis, and immunological diseases.

    • Leadership roles as a Principal Investigator, Research Coordinator, and Senior Researcher.

  • Significant Contributions to Scientific Knowledge:

    • Multiple peer-reviewed publications in well-regarded journals.

    • Research in shRNA-based antiviral therapies and autophagy in liver fibrosis, which have important clinical implications.

  • Teaching and Mentorship:

    • Experience teaching undergraduate and graduate students in microbiology, virology, medical biotechnology, and related fields.

    • Conducted training sessions in advanced molecular biology techniques such as PCR, ELISA, gene cloning, and viral culture methods.

  • Technical Expertise:

    • Skilled in molecular biology, viral diagnostics, and gene therapy techniques.

    • Proficient in specialized software for bioinformatics and data analysis

Education 🎓

Dr. Amiri Zadeh Fard holds a Ph.D. in Medical Virology from Shiraz University of Medical Sciences (2018-2023). He also earned an M.Sc. in Bacteriology from Shahre-Kord University of Medical Sciences (2016-2018), a B.Sc. from Shiraz Azad University (2011-2016), and an Associate Degree from Bandar Abbas University of Medical Sciences (1995-1998).

Experience 🌟

Dr. Amiri Zadeh Fard has held key research positions at the Gastroenterohepathology Research Center, Iran, since 2008. He has served as Principal Investigator, Research Coordinator, and Senior Researcher, significantly enhancing research efficiency through advanced viral analysis methods. Additionally, his role as a Laboratory Instructor and Technician has allowed him to mentor students and improve laboratory processes.

Research Interests On Microbiology🔬

His research focuses on biomedical engineering, virology, and biotechnology, particularly on shRNA-mediated viral suppression. His expertise spans DNA and RNA analysis, viral culture, gene cloning, and the development of novel therapeutic interventions for immunological diseases.

Awards & Honors 🏆

Dr. Amiri Zadeh Fard has received multiple accolades for his pioneering research in virology and biotechnology. His contributions to shRNA-based antiviral strategies have been widely recognized in the scientific community, earning him invitations as a reviewer for prestigious journals such as Clinica Chimica Acta.

Publications 📚

  • Therapeutic and Adverse Effects of Glucantime Used for Treatment of Cutaneous Leishmaniasis
    Authors: AS Beheshti M, Ghotbi Sh
    Year: 2007
    Citations: 25

  • Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia
    Authors: S Haghpanah, N Cohan, M Bordbar, A Bazrafshan, M Karimi, S Zareifar, …
    Year: 2021
    Citations: 12

  • Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran
    Authors: KB Lankarani, B Honarvar, HM Vardanjani, A Kharmandar, MM Gouya, …
    Year: 2020
    Citations: 11

  • Value of serological biomarker panel in diagnosis of atrophic gastritis and Helicobacter pylori Infection
    Authors: GR Sivandzadeh, SAZ Fard, A Zahmatkesh, MH Anbardar, KB Lankarani
    Year: 2023
    Citations: 7

  • Predictors of death in the liver transplantation adult candidates: an artificial neural networks and support vector machine hybrid-based cohort study
    Authors: KB Lankarani, B Honarvar, FS Pour, M Bagherpour, A Erjaee, …
    Year: 2022
    Citations: 4

  • Sustained Suppression of Fusion Gene‑mediated Human Respiratory Syncytial Virus Load by shRNA‑based Therapeutics
    Authors: ABB Amiri Zadeh S, Haniyeh Abuei, Ali Farhadi, Gholamreza Rafiei …
    Year: 2023
    Citations: 3*

  • Unlocking therapeutic potential: enhanced shRNA delivery with Tat peptide in the human respiratory Syncytial Virus Treatment
    Authors: SAZ Fard, H Abuei, AB Behbahani, GR Dehbidi, F Zare, M Nejabat, …
    Year: 2024
    Citations: 2

  • The Potential Role of Autophagy in Progression of Liver Fibrosis in Chronic Hepatitis B Patients Receiving Antiviral Treatment: A Brief Report
    Authors: KB Lankarani, A Sadidoost, M Fattahi, SA Fard, P Mokarram
    Year: 2024
    Citations: 1

  • Short hairpin RNA-mediated matrix gene silencing of human respiratory syncytial virus as a potent antiviral strategy
    Authors: ZAABB Saeid Amiri Zadeh Fard, Haniyeh Abuei, Ali Farhadi, Gholamreza …
    Year: 2023
    Citations: 1

  • Helicobacter pylori infection and inflammatory bowel disease: is there a link?
    Authors: M Nejabat, SAZ Fard, A Safarpour, SA Jirandeh
    Year: 2018
    Citations: 1

Conclusion 🎯

Dr. Saeid Amiri Zadeh Fard is a passionate researcher dedicated to advancing virology and biomedical engineering. His expertise in RNA-based therapeutics and extensive contributions to scientific research make him a valuable asset to the field. His leadership in research coordination and laboratory management continues to drive impactful discoveries in viral immunotherapy.

Lina Fan | Microbiology | Best Researcher Award

Published on by Forensic Scientist

Dr. Lina Fan | Microbiology | Best Researcher Award

Distinguished researcher | The Second Affiliated Hospital of Zhejiang University School of Medicine | China

Lina Fan is a distinguished researcher and physician, specializing in gut microbiota, immune microenvironment, and colorectal tumorigenesis. She obtained her Ph.D. from Zhejiang University and currently works as a gastroenterologist at the Second Affiliated Hospital of Zhejiang University School of Medicine. Her work focuses on the intricate relationship between gut microbiota and cancer, contributing significantly to the field with several impactful publications.

Profile

Scopus

Strengths for the Awards

  • Strong Academic Background:
    • Lina holds a Ph.D. from Zhejiang University, a prestigious institution, and works as a distinguished researcher and physician.
  • Research Focus:
    • Her research is centered on the highly impactful areas of gut microbiota, immune microenvironment, and colorectal cancer, all of which have significant implications for medical science.
  • High-Quality Contributions:
    • She has contributed significantly to the understanding of gut microbiota’s relationship with colorectal cancer and immune microenvironments, evidenced by the completion of substantial research on Bifidobacterium adolescentis and other microbiota in colorectal cancer.
  • Publications and Editorial Appointments:
    • Although there is no explicit mention of indexed journal publications, Lina holds editorial positions in well-regarded journals such as Cancer Immunology Research, Gut Microbes, and Cancer Communications, showcasing recognition from the research community.

Education 🎓

Lina Fan earned her Ph.D. from Zhejiang University, where she honed her expertise in gastrointestinal research. As a researcher and physician, she has contributed to advancements in understanding the immune microenvironment and gut microbiota’s role in colorectal cancer, laying the foundation for her future work.

Experience 🏥

Lina has served as a gastroenterologist and researcher at the Second Affiliated Hospital of Zhejiang University School of Medicine. She has been actively involved in studies examining the gut microbiota, immune system, and their relationship to digestive cancers, particularly colorectal cancer, producing multiple high-impact research articles in the process.

Research Interests On Microbiology🔬

Her research interests center on gut microbiota, the immune microenvironment, and their roles in colorectal tumorigenesis. Specifically, Lina has worked on understanding how specific microbes, like Bifidobacterium adolescentis, influence cancer development. Her ongoing projects explore the effects of gut microbiota on metabolic syndrome and the immune response in cancer.

Awards 🏆

Lina has been nominated for prestigious awards, including the Young Scientist Award and the Best Researcher Award, recognizing her groundbreaking work in cancer immunology and microbiome research. Her research has been recognized both nationally and internationally for its innovation and contributions to the scientific community.

Publications 📰

  • Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis
    • Authors: Sun, Y., Wang, Q., Jiang, Y., Chen, S., Fan, L.
    • Year: 2025
    • Citations: 0
  • Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
    • Authors: Jia, D., Wang, Q., Qi, Y., Chen, S., Wang, L.
    • Year: 2024
    • Citations: 47
  • Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
    • Authors: Lin, Y., Fan, L., Qi, Y., Chen, S., Wang, L.
    • Year: 2023
    • Citations: 0
  • Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
    • Authors: Lin, Y., Fan, L., Qi, Y., Chen, S., Wang, L.
    • Year: 2023
    • Citations: 19
  • Bifidobacterium adolescentis orchestrates CD143+ cancer-associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling-regulated GAS1
    • Authors: Chen, S., Fan, L., Lin, Y., Si, J., Wang, L.
    • Year: 2023
    • Citations: 14
  • Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206+ macrophagesIL-10 activation
    • Authors: Jia, D.-J.-C., Wang, Q.-W., Hu, Y.-Y., Chen, S.-J., Wang, L.-J.
    • Year: 2022
    • Citations: 70
  • Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-induced acute colitis by NLRP3 activation
    • Authors: Qu, S., Fan, L., Qi, Y., Liu, W., Si, J.
    • Year: 2021
    • Citations: 153
  • Akkermansia muciniphila suppresses colorectal tumorigenesis by inducing TLR2/NLRP3-mediated M1-like TAMs
    • Authors: Fan, L., Xu, C., Ge, Q., Chen, S., Wang, L.
    • Year: 2021
    • Citations: 94
  • Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization
    • Authors: Xu, C., Fan, L., Lin, Y., Si, J., Chen, S.
    • Year: 2021
    • Citations: 146
  • Bifidobacterium adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling
    • Authors: Fan, L., Qi, Y., Qu, S., Si, J., Chen, S.
    • Year: 2021
    • Citations: 141

Conclusion

Dr. Lina Fan’s research has made significant strides in exploring the complex relationship between gut microbiota and colorectal cancer. Her work continues to shape the field, with groundbreaking findings that may lead to novel therapeutic strategies. With her commitment to advancing medical knowledge, she is undoubtedly a key figure in the scientific community.